Nutrition, health and wellness product manufacturer and retailer[GNC Holdings Inc.] received the final $150m in Chinese firm Harbin Gloria Pharmaceuticals Co. Ltd.'s previously announced $300m strategic investment and has launched a Hong Kong-based China e-commerce JV with Harbin. Pittsburgh-based GNC on Feb. 13 said the firms plan a second-retail-focused JV in China likely in the 2019 second or third quarter following the completion of regulatory and legal requirements. GNC announced it cleared its hurdles with China’s regulatory agencies in November to receive the Harbin investment. (Also see "Health, Beauty And Wellness News: Vitamin Shoppe Trims Loss, GNC Closes Hayao Pact, AlchemLife In US" - HBW Insight, 8 November, 2018.)
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?